Madrigal Pharmaceuticals
Major Drugs - Conshohocken, Pennsylvania, US
Madrigal Pharmaceuticals Employees
Madrigal Pharmaceuticals Senior Management
Madrigal Pharmaceuticals Details
Madrigal (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. For more information, visit www.madrigalpharma.com.
Website:
https://www.madrigalpharma.com/
Employees:
527
HQ:
(267) 824-2827
Location:
Conshohocken, Pennsylvania, US
Revenue:
$31.1 million
Madrigal Pharmaceuticals Technologies
Load Balancers
Nginx
CMS
Drupal
Other
Microsoft Office 365
Hosting
Amazon AWS
Email Delivery
Amazon SES